cgoncology.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $510.76MM
CG Oncology is a developer of genitally engineered oncolytic immunotherapy treatments for individuals with advanced cancer.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/02/2023 | Series F | $105.02MM | $xx.xx | $615.24MM | Acorn Bioventures, Ally Bridge Group, Avidity Partners, Bvf Partners, Decheng Capital, Foresite Capital, Janus Henderson Investors, Longitude Capital, Malin Corporatoin, Ra Capital Management, Tcgx | |
Price per Share
$xx.xx
Shares Outstanding
81,587,937
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Acorn Bioventures, Ally Bridge Group, Avidity Partners, Bvf Partners, Decheng Capital, Foresite Capital, Janus Henderson Investors, Longitude Capital, Malin Corporatoin, Ra Capital Management, Tcgx
|
||||||
09/30/2022 | Series E | $120MM | $xx.xx | $405.38MM | Decheng Capital, Palm Drive Capital | |
Price per Share
$xx.xx
Shares Outstanding
112,422,700
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Decheng Capital, Palm Drive Capital
|
||||||
12/10/2020 | Series D | $47.3MM | $xx.xx | $212.97MM | Camford Capital, Kissei Pharmaceutical, Ori Healthcare Fund, Perservance Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
53,271,754
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Camford Capital, Kissei Pharmaceutical, Ori Healthcare Fund, Perservance Capital Management
|
||||||
03/18/2019 | Series C | $22MM | $xx.xx | $54.19MM | Ori Healthcare Fund, Perserverance Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
73,598,283
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Ori Healthcare Fund, Perserverance Capital Management
|
||||||
08/05/2015 | Series B | $10MM | $xx.xx | $31.64MM | Ally Bridge Group, Song Hong Fang, Whitesun Healthcare Ventures, Wi Harper Group | |
Price per Share
$xx.xx
Shares Outstanding
11,973,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ally Bridge Group, Song Hong Fang, Whitesun Healthcare Ventures, Wi Harper Group
|
||||||
07/28/2014 | Series A-1 | $3.57MM | $xx.xx | $11.9MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,075,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3
Key Investors
Undisclosed Investors
|